This year, the fields of sequencing and immunotherapy had hot announcements at the 35th JP Morgan Healthcare Conference. And we have exciting sessions planned as follow-ups on these themes at next week’s PMWC 2017 Silicon Valley conference. Sequencing Many of the established companies in the space –...
Q: First off congratulations on your new job at 10x Genomics. Can you tell us more about the role you have at 10x Genomics? A: Thank you! It is great to be at a cutting-edge technology company. My role at 10x is to lead the applications...
Precision medicine in concert with innovative and disruptive technologies, is creating a mountain of (big) data, moving into the clinic and finding wider and wider acceptance across hospitals and healthcare networks, based on its promise and potential for enhancing patient care via improved diagnostics and...
There are many indications that our current healthcare system is too complex and too bureaucratic. Changes are needed as pressures from various stakeholders mount, and payors, in particular, have suggested different approaches to tackle this issue. “Value-based” versus "fee-for-service” pricing models need to be considered...
CRISPR-Cas9, the widely hailed genome-editing tool is under scrutiny, not for the possible ethical ramifications of CRISPR being employed as a human genome alteration tool, but rather for who should own the foundational and lucrative patent rights: the University of California, Berkeley, or the Broad...
For the second consecutive year, UC San Francisco is co-hosting the Precision Medicine World Conference (PMWC), which is being held in January 2017. Renamed this year from the Personalized Medicine World Conference, the annual forum attracts more than 1,000 recognized authorities and experts to speak about...
An update on the Cancer Moonshot Initiative and more at the 11th PMWC 2017 Silicon Valley with 250+ speakers and 50+ sessions While its creation was only announced earlier this year, with Vice President Joe Biden at the helm instilling hope and calling for action, the...
Q: Precision medicine will have a huge economic impact on health care. As a result, value-based versus cost-based pricing needs to be considered from a patient, pharma, and payor perspective. What are some of the challenges of implementing value-based pricing, and how can we ensure...
Q: You helped make one of the most monumental discoveries in biology that allows to alter an organism's DNA. Can you tell us how this came about? What lead to the discovery? A: CRISPR-Cas9 gene editing technology is the result of a fundamental, curiosity-driven science project...
Q: Immunotherapy has rapidly evolved into a game-changing cancer treatment strategy for a wide array of different cancers, though some patients respond better than others.How important are biomarker assays for patient-selection to guide clinicians to use immunotherapies and for monitoring response and why? A: We’re only...
